Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical AdvisorClinical Challenge: Vomiting and Weakness

A 38-year-old with two weeks of vomiting presents with tachycardia, weakness, and an ECG showing diffuse ST depression with T-U fusion waves. The pattern points away from ischemia and toward severe hypokalemia, a diagnosis with immediate prescribing implications for NPs/PAs managing vomiting patients across settings.


Clinical Considerations

  • Severe hypokalemia (K+ less than 2.5 mEq/L) produces ECG changes including ST depression, T-U fusion, and QRS widening that can mimic ischemia and precede fatal arrhythmia
  • Three first-line antiemetics prolong QT and are contraindicated when hypokalemia is suspected: ondansetron, metoclopramide, and prochlorperazine
  • Safe antiemetic alternatives include diphenhydramine, benzodiazepines, and dexamethasone, though dexamethasone may worsen metabolic alkalosis
  • Epinephrine and sodium bicarbonate both lower serum potassium, critical to know if a hypokalemic patient arrests

Practice Applications

  • Reconsider your antiemetic default when vomiting patients present with weakness, tachycardia, or any ECG abnormality
  • Order potassium and an ECG together in prolonged vomiting with systemic symptoms; don’t wait for labs to drive the clinical picture
  • Admit when K+ is below 2.5 mEq/L, ECG changes are present, or significant muscle weakness exists

More Clinical Challenges

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form